Contents

Current Cancer Drug Targets, Volume 5 - Number 7

Editorial [Hot Topic: Novel Non-Cytotoxic Approaches For Cancer Therapy: Potential Targets and Pathways Amenable to Single Agent Multimodal Therapeutic Approaches (Guest Editor: Andrew Mazar)]

, 5(7): 469 - 470

Andrew Mazar


DOI: 10.2174/156800905774574057




Hypomethylation of Urokinase (uPA) Promoter in Breast and Prostate Cancer: Prognostic and Therapeutic Implications

, 5(7): 471 - 488

Pouya Pakneshan, Moshe Szyf and Shafaat A. Rabbani


DOI: 10.2174/156800905774574011




Targeting Invasion Induction as a Therapeutic Strategy for the Treatment of Cancer

, 5(7): 489 - 503

Donna L. Livant


DOI: 10.2174/156800905774574002




Cancer Therapy Through Control of Cell Migration

, 5(7): 505 - 518

Eugene G. Levin


DOI: 10.2174/156800905774574048




Inhibition of Angiogenesis by Cleaved High Molecular Weight Kininogen (HKa) and HKa Domain 5

, 5(7): 519 - 528

Keith R. McCrae, Fernando Donate, Sergei Merkulov, Danyu Sun, Xiaoping Qi and David E. Shaw


DOI: 10.2174/156800905774574039




Anti-Angiogenic and Anti-Tumor Properties of Proteasome Inhibitors

, 5(7): 529 - 541

Kenyon G. Daniel, Deborah J. Kuhn, Aslamuzzaman Kazi and Q. P. Dou


DOI: 10.2174/156800905774574075




Control of Copper Status for Cancer Therapy

, 5(7): 543 - 549

Vicki L. Goodman, George J. Brewer and Sofia D. Merajver


DOI: 10.2174/156800905774574066




Cellular and Molecular Surrogate Markers to Monitor Targeted and Non- Targeted Antiangiogenic Drug Activity and Determine Optimal Biologic Dose

, 5(7): 551 - 559

Yuval Shaked, Guido Bocci, Raquel Munoz, Shan Man, John M.L. Ebos, Daniel J. Hicklin, Francesco Bertolini, Robert D'Amato and Robert S. Kerbel


DOI: 10.2174/156800905774574020




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science